TYNDALL CAPITAL PARTNERS L P sold 0.7% of their position (5.42K shares) of TRAWS PHARMA, INC. on the open market
Open‑market sale worth $15.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/9/2019ACC: 0000905718-19-000753
10% Owner
Since Jun 2019
-5.42K
Net shares
Net seller
$15.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
5.42K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−400.00
Price / share
$2.75
Trade value
$1.10K
% of position
0.0%
9/5/2019
802.51K→802.11K
Common Stock
Indirect
Shares
−5.01K
Price / share
$2.78
Trade value
$13.95K
% of position
0.6%
9/6/2019
802.11K→797.09K
Total
Net shares
−5.42K
Net value
-$15.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/5/2019 | S · Sale | −400.00 | $2.75 | $1.10K | 0.0% | 802.51K | 802.11K |
| Common Stock Indirect | 9/6/2019 | S · Sale | −5.01K | $2.78 | $13.95K | 0.6% | 802.11K | 797.09K |
| Total | −5.42K | -$15.05K | ||||||
Derivative Transactions0
No derivative transactions reported